Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online

Today is International Women's Day and we are joining the campaign to #InspireInclusion πŸ’™

We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference πŸ‘©β€βš•οΈπŸ©Ί

#IWD2024

As March is #myelomaawarenessmonth, we wanted to share an update from the 20th International Myeloma Society (IMS) Annual Meeting | The value of #circulating #tumor cells for the staging of patients with #NDMM @BrunoPaiva_UNAV πŸ“£πŸ©Έ

πŸ‘‰ https://www.vjhemonc.com/video/vhnenc6jsa-the-value-of-circulating-tumor-cells-for-the-staging-of-patients-with-ndmm/

#VJHemOnc #MMsm

March is #prostatecancer awareness month and what better time to hear about the latest in prostate cancer therapies?

We have updates from the Phase II #BRCAAway trial, demonstrating the benefits of #combinationtherapy over #sequentialtherapy πŸ”¦πŸŽ₯

πŸ‘‰ https://www.vjoncology.com/video/k0etnzlaq1c-brcaaway-abiraterone-with-olaparib-in-mcrpc-with-hrr-mutations/

Load More

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online
The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

Today is International Women's Day and we are joining the campaign to #InspireInclusion πŸ’™

We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference πŸ‘©β€βš•οΈπŸ©Ί

#IWD2024

As March is #myelomaawarenessmonth, we wanted to share an update from the 20th International Myeloma Society (IMS) Annual Meeting | The value of #circulating #tumor cells for the staging of patients with #NDMM @BrunoPaiva_UNAV πŸ“£πŸ©Έ

πŸ‘‰ https://www.vjhemonc.com/video/vhnenc6jsa-the-value-of-circulating-tumor-cells-for-the-staging-of-patients-with-ndmm/

#VJHemOnc #MMsm

March is #prostatecancer awareness month and what better time to hear about the latest in prostate cancer therapies?

We have updates from the Phase II #BRCAAway trial, demonstrating the benefits of #combinationtherapy over #sequentialtherapy πŸ”¦πŸŽ₯

πŸ‘‰ https://www.vjoncology.com/video/k0etnzlaq1c-brcaaway-abiraterone-with-olaparib-in-mcrpc-with-hrr-mutations/

Load More